| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/20/2008 | US7374778 Enhanced transport using membrane disruptive agents |
| 05/20/2008 | US7374777 Crosslinked, molecular orientated fibers |
| 05/20/2008 | US7374774 Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers |
| 05/20/2008 | US7374770 Topical applying decarboxylase inhibitor |
| 05/20/2008 | US7374747 topical delivery of a quick-breaking temperature sensitive foam antibacterial composition to the skin; clindamycin phosphate and a foaming agent comprising an C1-C6 alcohol, a C14-C22 alcohol, a surfactant, water, aerosol propellant; dispensed from pressurized container; acne |
| 05/20/2008 | US7374745 Ultrasound contrast agents |
| 05/20/2008 | US7374744 Supplying contrast agent in microbubbles which reradiates ultrasonic frequency; detection |
| 05/20/2008 | US7374693 Water decontamination apparatus and method |
| 05/20/2008 | US7374570 Polymer compositions for intraluminal stent |
| 05/20/2008 | US7374565 Bi-directional infuser pump with volume braking for hydraulically controlling an adjustable gastric band |
| 05/20/2008 | CA2499546C Sustained released delivery of amphetamine salts |
| 05/20/2008 | CA2438218C Modulated release particles for aerosol delivery |
| 05/20/2008 | CA2368866C Method for coating pharmaceutical dosage forms |
| 05/20/2008 | CA2366862C Transdermal therapeutic system and process for its production |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/20/2008 | CA2257841C Medicinal aerosol formulations of formoterol |
| 05/20/2008 | CA2223510C Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2171999C Pharmaceutical formulations in form of thixotropic gel |
| 05/20/2008 | CA2166931C Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 05/17/2008 | CA2618240A1 Sustained-release formulations of topiramate |
| 05/15/2008 | WO2008058272A2 Polymer-based antimicrobial agents, methods of making said agents, and products and applications using said agents |
| 05/15/2008 | WO2008058234A2 Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility |
| 05/15/2008 | WO2008058220A2 Transdermal drug delivery system |
| 05/15/2008 | WO2008058210A2 Local administration of gallium compositions to treat pain |
| 05/15/2008 | WO2008058035A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 05/15/2008 | WO2008057934A1 Encapsulated soy extracts and process for preparing same |
| 05/15/2008 | WO2008057845A2 Bioabsorbable implantable material fortified with antibiotics for localized delivery of drugs |
| 05/15/2008 | WO2008057464A2 Compositions and methods for improving the bioavailability of liothyronine |
| 05/15/2008 | WO2008057442A2 Eyelid scrub composition |
| 05/15/2008 | WO2008057409A2 Sanitizing surfaces |
| 05/15/2008 | WO2008057267A2 Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations |
| 05/15/2008 | WO2008057266A2 Dry granulation binders, products, and use thereof |
| 05/15/2008 | WO2008057136A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | WO2008057058A1 Oral pharmaceutical compositions |
| 05/15/2008 | WO2008057048A1 Nano & micro-sized particles of statin compounds and process for forming same |
| 05/15/2008 | WO2008056926A1 Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate |
| 05/15/2008 | WO2008056822A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| 05/15/2008 | WO2008056786A1 Composition for skin or mucosal application |
| 05/15/2008 | WO2008056657A1 Lyophilized preparation comprising phenanthridine derivative |
| 05/15/2008 | WO2008056623A1 Composition for introduction of nucleic acid |
| 05/15/2008 | WO2008056344A2 Method of producing microcapsules |
| 05/15/2008 | WO2008056263A2 Quality control methods for oil-in-water emulsions containing squalene |
| 05/15/2008 | WO2008056200A1 Oral pharmaceutical compositions of simethicone |
| 05/15/2008 | WO2008056139A2 Transdermal therapy |
| 05/15/2008 | WO2008056001A1 Solid dosage form with a film containing an active substance, as well as its method of production |
| 05/15/2008 | WO2008055996A1 Oral dosage form comprising tri-substituted glycerol compounds |
| 05/15/2008 | WO2008055966A1 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 05/15/2008 | WO2008055965A1 Melt-processed imatinib dosage form |
| 05/15/2008 | WO2008055951A1 Method for mixing powders |
| 05/15/2008 | WO2008055871A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/15/2008 | WO2008055628A1 Liposome preparation by single-pass process |
| 05/15/2008 | WO2008055626A1 Protein-containing substance with increased thermal stability |
| 05/15/2008 | WO2008055620A2 Method for the production of an agent against an infectious disease |
| 05/15/2008 | WO2008055386A1 A water-soluble pharmaceutical composition for injection of 17-allyl amino-17-demethoxy geldanamycin |
| 05/15/2008 | WO2008055363A1 Herbal product comprising cinnamon, bitter melon and omega-3 fatty acids |
| 05/15/2008 | WO2008030949A3 Stable polyunsaturated fatty acid emulsions and methods for inhibitintg, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
| 05/15/2008 | WO2008030567A3 Dry powder compound formulations and uses thereof |
| 05/15/2008 | WO2008027522A3 Solid composites of a calicum receptor-active compound |
| 05/15/2008 | WO2008022032A3 Topical pharmaceutical compositions comprising calcium-channel blocker and method of using same |
| 05/15/2008 | WO2008013808A3 High dose orally dissolvable/disintegrable lyophilized dosage form |
| 05/15/2008 | WO2008011194A3 Transmucosal delivery devices with enhanced uptake |
| 05/15/2008 | WO2008001311A3 Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate |
| 05/15/2008 | WO2007133508A8 Water dispersible films for delivery of active agents to the epidermis |
| 05/15/2008 | WO2007124082A3 Buffering agents for biopharmaceutical formulations |
| 05/15/2008 | WO2007113008A3 Opaque container comprising food or pharmaceutical products or herbal(s) |
| 05/15/2008 | WO2007112286A3 Stabilized compositions containing alkaline labile drugs |
| 05/15/2008 | WO2007107787A3 Liquid and solid dosage formulations containing date fruit (phoenix dactylifera) |
| 05/15/2008 | WO2007084916A3 Thimerosal removal device |
| 05/15/2008 | WO2007084765A3 Injectable combination therapy for eye disorders |
| 05/15/2008 | WO2007017254A3 Method for production of particles of pharmaceutical substances collections of said particles and the use thereof |
| 05/15/2008 | WO2005086954A3 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 05/15/2008 | US20080114458 Intervertebral disc treatment devices and methods |
| 05/15/2008 | US20080114339 Heart assist device with expandable impeller pump |
| 05/15/2008 | US20080114293 Device and method for combining a treatment agent and a gel |
| 05/15/2008 | US20080114287 Ultrasound Microbubble Mediated Genes Delivery System |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114057 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/15/2008 | US20080113960 Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 05/15/2008 | US20080113936 Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates |
| 05/15/2008 | US20080113916 Povidone-Containing Carriers for Polypeptide Growth Factors |
| 05/15/2008 | US20080113035 medical equipment, drug delivery devices or implants containing antimitotic agents such as taxol or diterpenes, used for treating inflammatory diseases such as psoriasis or multiple sclerosis |
| 05/15/2008 | US20080113031 seamless capsules having cores containing drugs, to enhance bioavailability, sustained release or time release of drugs |
| 05/15/2008 | US20080113030 Sustained release tamsulosin formulations |
| 05/15/2008 | US20080113029 Color-Coded and Sized Loadable Polymeric Particles for Therapeutic and/or Diagnostic Applications and Methods of Preparing and Using the Same |
| 05/15/2008 | US20080113028 Novel Block Copolymer, Micelle Preparation, And Anticancer Agent Containing The Same As Active Ingredient |
| 05/15/2008 | US20080113027 Water insoluble polymer matrix for drug delivery |
| 05/15/2008 | US20080113026 Layered pharmaceutical formulations |
| 05/15/2008 | US20080113025 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113023 comprising a first layer containing 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-ylmethyl]-biphenyl-2-carboxylic acid dispersed in dissolving matrices and a second layer containing hydrochlorothiazide in a disintegrating tablet matrix |
| 05/15/2008 | US20080113022 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
| 05/15/2008 | US20080113021 particles comprising ibuprofen and a taste masking water soluble acid and matrice comprising a second water soluble acid; immediate release tablet capable of being chewed or disintegrated in the mouth |
| 05/15/2008 | US20080113020 Solid pharmaceutical composition comprising telithromycin |
| 05/15/2008 | US20080113019 shell sheets comprising vegetable polysaccharide and polyglutamic acid, having both sufficient strength and elongation, superior adhesiveness and transparency, and a low burden on drying |
| 05/15/2008 | US20080113018 Encapsulation Method for Compounds |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/15/2008 | US20080113016 Method for Prevention or Treatment of Inflammatory Disease |
| 05/15/2008 | US20080113015 drug delivery devices comprising capsules containing drugs distributed within an aqueous phase in the interior of the capsule |